CTRI/2022/09/045548
Active, not recruiting
Phase 2
Clinical trial to evaluate the therapeutic efficacy of two herbal drugs STERISWAS-G1 and STERICHARM-HSA in reducing the viral load among HIV/AIDS patients, and also to document file improvement in the conditions of HIV/AIDS patients opportunistic coinfections
MVR Ayurveda medical college0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- MVR Ayurveda medical college
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •those with ART regime and not under life threatening conditions
Exclusion Criteria
- •those with serious systemic illness
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Thalidomide effects in COVID-19Covid 19.Covid 19IRCT20110423006257N3Arak University of Medical Sciences66
Recruiting
Phase 3
Diferent doses of lactase in subjects with intolerance lactoseRBR-53hjzkutracom Indústria e Comércio Ltda.
Active, not recruiting
Not Applicable
Testing a food supplement in improving strength, power and mental alertnessHealthy volunteerNot ApplicableISRCTN86507492Farmaceutici Procemsa S.p.A.60
Completed
Phase 2
A Clinical study on cervical spondylosis using thengaai thuruval ottradam (external therapy)Health Condition 1: M478- Other spondylosisCTRI/2021/02/031542Government Siddha medical college and hospital40
Active, not recruiting
Not Applicable
Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis - Tretinoin bei AKactinic keratosisMedDRA version: 9.1Level: LLTClassification code 10000614Term: Actinic keratosisEUCTR2007-000093-23-DEAlmirall Hermal GmbH